Calcitonin-salmon
FDA-approved salmon calcitonin — specialty/limited osteoporosis role.
What it's for
FDA-approved salmon calcitonin — specialty/limited osteoporosis role.
What it's for
Salmon calcitonin is a 32–amino-acid peptide more potent at human calcitonin receptors (lock-and-key landing spots on cells) than human calcitonin. Used for hypercalcemia of malignancy and historically for osteoporosis; nasal spray osteoporosis use has declined due to efficacy/safety considerations versus modern agents.
What it does for the body
Used for hypercalcemia of malignancy and historically for osteoporosis; nasal spray osteoporosis use has declined due to efficacy/safety considerations versus modern agents. People often hear about it through clinics, forums, or news — this guide sticks to what published research and regulators actually support.
What it targets
Calcitonin receptors (lock-and-key landing spots on cells) activation inhibits bone-resorbing cell-mediated bone resorption and can lower serum calcium. Researchers map these ideas in cells and animals first; human proof has to clear a higher bar.
Research context
Bottom line for readers: Calcitonin-salmon has a defined FDA-approved story. Use the citations tab to open labels and trial registries, and treat anything beyond the label as unverified.
Studied for (literature interest)
- Bones research interest (educational tag)
Cautions (educational)
- Educational only — not medical advice.
- DrPep does not offer medical consultations, dosing guidance, suppliers, or peptide sales.
Citations / starters
- FDA search: Calcitonin-salmon — FDA.gov search
- ClinicalTrials.gov search: Calcitonin-salmon — U.S. clinical trials registry
- Drugs@FDA search: Calcitonin-salmon — FDA drug database (if approved)
- PubMed search: Calcitonin-salmon — NCBI PubMed
- PubMed Central search: Calcitonin-salmon — NCBI PMC